Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 29 Oct 2024 – 20 Aug 2026, limited by Mirae Asset Nifty Total Market Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Mirae Asset Nifty Total Market Index Fund | Nifty 500 |
|---|---|---|
| 29 Oct 2024 | ₹100.00 | ₹100.00 |
| 23 Dec 2024 | ₹98.48 | ₹98.32 |
| 16 Feb 2025 | ₹90.38 | ₹90.52 |
| 12 Apr 2025 | ₹90.71 | ₹91.04 |
| 06 Jun 2025 | ₹101.41 | ₹101.62 |
| 31 Jul 2025 | ₹100.55 | ₹100.53 |
| 24 Sep 2025 | ₹101.70 | ₹101.68 |
| 18 Nov 2025 | ₹104.31 | ₹104.52 |
| 12 Jan 2026 | ₹102.55 | ₹103.14 |
| 08 Mar 2026 | ₹98.02 | ₹98.62 |
| 02 May 2026 | ₹99.16 | ₹99.51 |
| 26 Jun 2026 | ₹101.45 | ₹101.40 |
| 20 Aug 2026 | ₹103.49 | ₹103.15 |
| Metric | Mirae Asset · Regular · IDCW NAV ₹10.43 Very High risk ★★☆☆☆ 1Y | Category median Index Funds · 271 funds |
|---|---|---|
| +1.90% | +4.72% | |
| — | +7.52% | |
| — | +8.28% | |
| — | +9.00% | |
| +1.91% | +7.27% | |
| +4.77% | — | |
| — | +7.88% | |
| — | +10.94% | |
| — | +9.63% | |
| Risk | ||
| 14.52% | 13.54% | |
| -0.32 | 0.11 | |
| -0.43 | 0.15 | |
| -15.30% | -15.67% | |
| Nifty 500 | — | |
| — | -0.05% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 99.5% | |
| 0.99% | 0.88% | |
| ₹50.01Cr | ₹181.49Cr | |
| None | — | |
| None | — | |
| ₹99 | — | |
| ₹5.00K | — | |
| — | 38% | |
| Ekta Gala · 1.9y | — | |
| 29 Oct 2024 | — | |
| 751 | — | |
| 28.5% | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.